Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer

Q Li, HL Sham - Expert Opinion on Therapeutic Patents, 2002 - Taylor & Francis
Antimitotic agents have generated considerable interest among cytotoxic agents due to the
tremendous success of the taxanes and the widespread use of the Vinca alkaloids in clinical …

Synthesis and biological evaluation of novel pyrazole derivatives with anticancer activity

A Balbi, M Anzaldi, C Macciò, C Aiello, M Mazzei… - European journal of …, 2011 - Elsevier
We synthesized thirty-six novel pyrazole derivatives and studied their antiproliferative activity
in human ovarian adenocarcinoma A2780 cells, human lung carcinoma A549 cells, and …

[HTML][HTML] Biological mechanism profiling using an annotated compound library

DE Root, SP Flaherty, BP Kelley, BR Stockwell - Chemistry & biology, 2003 - cell.com
We present a method for testing many biological mechanisms in cellular assays using an
annotated library of 2036 small organic molecules. This annotated compound library …

Synthesis of (Z)-(arylamino)-pyrazolyl/isoxazolyl-2-propenones as tubulin targeting anticancer agents and apoptotic inducers

A Kamal, VS Reddy, AB Shaik, GB Kumar… - Organic & …, 2015 - pubs.rsc.org
A new class of pyrazole and isoxazole conjugates were synthesized and evaluated for their
cytotoxic activity against various human cancer cell lines. These compounds have shown …

Induction of apoptosis in estrogen dependent and independent breast cancer cells by the marine terpenoid dehydrothyrsiferol

MK Pec, A Aguirre, K Moser-Thier, JJ Fernández… - Biochemical …, 2003 - Elsevier
Breast cancer (BCA) represents the highest incidence of death in 35-to 60-year-old women.
Above all, hormone unresponsive BCA is still associated with poorer prognosis than …

Synthesis and mechanism of action of novel pyrimidinyl pyrazole derivatives possessing antiproliferative activity

H Ohki, K Hirotani, H Naito, S Ohsuki, M Minami… - Bioorganic & medicinal …, 2002 - Elsevier
Pyrimidinyl pyrazole derivatives 1–4, prepared as a new scaffold of an anti-tumor agent,
showed antiproliferative activity against human lung cancer cell lines and inhibited tubulin …

Synthesis and biological evaluation of some new class of benzothiazole–pyrazole ligands containing arene ruthenium, rhodium and iridium complexes

L Shadap, JL Tyagi, KM Poluri, S Novikov… - Transition Metal …, 2021 - Springer
Metal complexes 1–9 have been synthesized by reacting the benzothiazole–pyrazole
derivative ligands (L1, L2 and L3) with the metal precursors of ruthenium (Ru), rhodium (Rh) …

Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives. II. Optimization of the phenylpiperazine moiety of 1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-3 …

H Naito, S Ohsuki, M Sugimori, R Atsumi… - Chemical and …, 2002 - jstage.jst.go.jp
A series of novel 3-substituted-1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-1-trans-propenes in
order to improve the in vitro and in vivo activity of our prototype 3-[4-(3-chlorophenyl)-1 …

Synthesis and antitumor activity of novel pyrimidinyl pyrazole derivatives. III. Synthesis and antitumor activity of 3-phenylpiperazinyl-1-trans-propenes

H Naito, S Ohsuki, R Atsumi, M Minami… - Chemical and …, 2005 - jstage.jst.go.jp
A series of novel 3-[4-phenyl-1-piperazinyl]-1-[5-methyl-1-(2-pyrimidinyl)-4-pyrazolyl]-1-trans-
propenes and related compounds were synthesized and evaluated by their cytotoxic activity …

Substituted-triazolopyrimidines as anticancer agents

MR Schmitt, DR Kirsch, JE Harris, CF Beyer… - US Patent …, 2008 - Google Patents
The invention provides a method of treating or inhibiting the growth of cancerous tumor cells
and associated diseases in a mammal in need thereof which comprises administering to …